JP2010524930A5 - - Google Patents

Download PDF

Info

Publication number
JP2010524930A5
JP2010524930A5 JP2010504040A JP2010504040A JP2010524930A5 JP 2010524930 A5 JP2010524930 A5 JP 2010524930A5 JP 2010504040 A JP2010504040 A JP 2010504040A JP 2010504040 A JP2010504040 A JP 2010504040A JP 2010524930 A5 JP2010524930 A5 JP 2010524930A5
Authority
JP
Japan
Prior art keywords
pyrido
pyrimidin
dihydro
benzonitrile
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010504040A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010524930A (ja
JP5498374B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/004208 external-priority patent/WO2008130481A1/en
Publication of JP2010524930A publication Critical patent/JP2010524930A/ja
Publication of JP2010524930A5 publication Critical patent/JP2010524930A5/ja
Application granted granted Critical
Publication of JP5498374B2 publication Critical patent/JP5498374B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010504040A 2007-04-17 2008-03-31 2−シアノフェニル縮合複素環式化合物および組成物、ならびにその使用 Expired - Fee Related JP5498374B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US92510907P 2007-04-17 2007-04-17
US60/925,109 2007-04-17
US1051208P 2008-01-08 2008-01-08
US61/010,512 2008-01-08
PCT/US2008/004208 WO2008130481A1 (en) 2007-04-17 2008-03-31 2-cyanophenyl fused heterocyclic compounds, and compositions and uses thereof

Publications (3)

Publication Number Publication Date
JP2010524930A JP2010524930A (ja) 2010-07-22
JP2010524930A5 true JP2010524930A5 (enExample) 2011-04-07
JP5498374B2 JP5498374B2 (ja) 2014-05-21

Family

ID=39875785

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010504040A Expired - Fee Related JP5498374B2 (ja) 2007-04-17 2008-03-31 2−シアノフェニル縮合複素環式化合物および組成物、ならびにその使用

Country Status (12)

Country Link
US (2) US8076345B2 (enExample)
EP (1) EP2139334B1 (enExample)
JP (1) JP5498374B2 (enExample)
CN (1) CN101677569B (enExample)
CA (1) CA2682692A1 (enExample)
CY (1) CY1114382T1 (enExample)
DK (1) DK2139334T3 (enExample)
ES (1) ES2427999T3 (enExample)
HR (1) HRP20130867T1 (enExample)
PL (1) PL2139334T3 (enExample)
PT (1) PT2139334E (enExample)
WO (1) WO2008130481A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009110985A2 (en) 2008-02-29 2009-09-11 Renovis, Inc. Amide compounds, compositions and uses thereof
WO2010066629A2 (en) * 2008-12-09 2010-06-17 F. Hoffmann-La Roche Ag Novel azaindoles
UA112517C2 (uk) 2010-07-06 2016-09-26 Новартіс Аг Тетрагідропіридопіримідинові похідні
AU2014253493B2 (en) * 2010-07-06 2016-04-14 Novartis Ag Tetrahydro-pyrido-pyrimidine derivatives
EA201490164A1 (ru) * 2011-06-27 2014-04-30 Новартис Аг Твердые формы и соли производных тетрагидропиридопиримидина
ES2661510T3 (es) 2011-12-15 2018-04-02 Novartis Ag Uso de inhibidores de la actividad o función de PI3K
CN103497149A (zh) * 2013-10-08 2014-01-08 南京复兴生物科技有限公司 一种5-氨甲基吡啶衍生物的制备方法
US10183937B2 (en) 2014-12-09 2019-01-22 Bayer Aktiengesellschaft 1,3-thiazol-2-yl substituted benzamides
CN107207507B (zh) 2014-12-09 2020-11-06 拜耳公司 1,3-噻唑-2-基取代的苯甲酰胺
WO2017049498A1 (zh) * 2015-09-23 2017-03-30 前湾医药科技(深圳)有限公司 一种咪唑并吡啶类化合物与在制备pi3k抑制剂中的应用
AU2020232616A1 (en) * 2019-03-01 2021-09-09 Revolution Medicines, Inc. Bicyclic heterocyclyl compounds and uses thereof
CA3139019A1 (en) 2019-05-31 2020-12-03 Chiesi Farmaceutici S.P.A. Amino quinazoline derivatives as p2x3 inhibitors
CN114222741B (zh) 2019-05-31 2025-12-30 奇斯药制品公司 作为p2x3抑制剂的吡啶并嘧啶类衍生物
TWI793704B (zh) * 2020-08-06 2023-02-21 大陸商北京泰德製藥股份有限公司 Sos1抑制劑、包含其的藥物組合物及其用途
US20230416233A1 (en) 2020-11-27 2023-12-28 Chiesi Farmaceutici S.P.A. (aza)quinoline 4-amines derivatives as p2x3 inhibitors
AU2021386405A1 (en) 2020-11-27 2023-05-25 Chiesi Farmaceutici S.P.A. Phthalazine derivatives as p2x3 inhibitors
MX2023005803A (es) 2020-11-27 2023-05-29 Chiesi Farm Spa Derivados de amino-quinazolina como inhibidores del purinorreceptor 3 p2x (p2x3).
AU2023406476A1 (en) 2022-12-02 2025-06-05 Neumora Therapeutics, Inc. Methods of treating neurological disorders

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3424761A (en) * 1966-03-07 1969-01-28 Robins Co Inc A H 3-ureidopyrrolidines
US3424760A (en) * 1966-03-07 1969-01-28 Robins Co Inc A H 3-ureidopyrrolidines
DE2502588A1 (de) 1975-01-23 1976-07-29 Troponwerke Dinklage & Co Basisch substituierte derivate des 7-amino-2-chinolons, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
EP1177188B1 (en) 1999-05-12 2005-10-12 Ortho-McNeil Pharmaceutical, Inc. Pyrazole carboxamides useful for the treatment of obesity and other disorders
WO2001051490A1 (en) * 2000-01-14 2001-07-19 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methanocarba cycloalkyl nucleoside analogues
US6531478B2 (en) 2000-02-24 2003-03-11 Cheryl P. Kordik Amino pyrazole derivatives useful for the treatment of obesity and other disorders
MXPA03000458A (es) 2000-07-20 2004-06-02 Neurogen Corp Ligandos receptores de capsaicina.
DE60110844T2 (de) 2001-01-02 2006-01-12 F. Hoffmann-La Roche Ag Chinazolone derivate als alfa 1a/b adrenozeptor antagonisten
WO2002088079A2 (en) * 2001-05-01 2002-11-07 Bristol-Myers Squibb Company Dual inhibitors of pde 7 and pde 4
GB0206033D0 (en) 2002-03-14 2002-04-24 Pfizer Ltd Compounds useful in therapy
EP1552842A1 (en) * 2002-06-07 2005-07-13 Kyowa Hakko Kogyo Co., Ltd. Bicyclic pyrimidine derivatives
GB0225908D0 (en) 2002-11-06 2002-12-11 Pfizer Ltd Treatment of female sexual dysfunction
AU2003299797A1 (en) 2002-12-19 2004-07-14 Neurogen Corporation Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
TW200530235A (en) * 2003-12-24 2005-09-16 Renovis Inc Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
US7297700B2 (en) * 2005-03-24 2007-11-20 Renovis, Inc. Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
JP5198256B2 (ja) * 2005-05-04 2013-05-15 エボテク エージー 縮合複素環式化合物、並びにそれらの組成物及び使用
US8653091B2 (en) * 2007-04-02 2014-02-18 Evotec Ag Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof
US8546388B2 (en) * 2008-10-24 2013-10-01 Purdue Pharma L.P. Heterocyclic TRPV1 receptor ligands

Similar Documents

Publication Publication Date Title
JP2010524930A5 (enExample)
JP2010523562A5 (enExample)
US20190040025A1 (en) Indoleamine 2,3-dioxygenase inhibitor, preparation method therefor, and application
AU2014222756B2 (en) Inhibitors of histone demethylases
JP2008546639A5 (enExample)
JP2012502986A5 (enExample)
AU2016201584B2 (en) Phosphatidylinositol 3-kinase inhibitors
AU2013234009B2 (en) Heterocyclyl compounds as MEK inhibitors
JP5066175B2 (ja) ヒスタミンh4受容体のモジュレーターとしてのベンゾイミダゾール−2−イルピリミジンおよびピラジン
AU2002323475B2 (en) 2-aroylimidazole compounds for treating cancer
JP2011514894A5 (enExample)
US8076345B2 (en) 2-cyanophenyl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine compounds, compositions and uses thereof
CN105473573B (zh) 用作激酶抑制剂的咔唑甲酰胺化合物
JP5204091B2 (ja) 新規なベンジル(ヘテロサイクリックメチル)アミン構造を有するピリミジン化合物及びこれを含有する医薬
EP3475284A1 (en) Pyrrolobenzodiazepines and conjugates thereof
JP2008512348A5 (enExample)
CN103200822A (zh) 2-取代-8-烷基-7-氧代-7,8-二氢吡啶并[2,3-d]嘧啶-6-腈和其应用
WO2017101884A1 (zh) 吲哚胺2,3-双加氧酶抑制剂及其制备方法与应用
WO2018133716A1 (zh) 杂环脲类化合物及其药物组合物和应用
TW201107318A (en) Furazanobenzimidazoles
AU2015335783B2 (en) Tricyclic atropisomer compounds
JP2007509043A5 (enExample)
AU2018338098A1 (en) Cyclic iminopyrimidine derivatives as kinase inhibitors
JP2019510801A5 (enExample)
JP2011526911A (ja) ベンゾイミダゾール−2−イルピリミジン誘導体を製造する方法